Showing results (1951-1960 of 2,317) with videos related to

Sort By:
Pageof 232
Global Heart|March 4, 2017
A Comprehensive Needs Assessment Tool for Planning RHD Control Programs in Limited Resource SettingsLiesl J Zühlke, David A Watkins, Susan Perkins, et al.
The Annals of Thoracic Surgery|August 16, 2024
Donation After Circulatory Death Cardiac Recovery Technique: Single-Center Observational OutcomesChetan Pasrija, Alexandra DeBose-Scarlett, Hasan K Siddiqi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
CD80/CD86 costimulation regulates acute vascular rejectionKaroline A Hosiawa, Hao Wang, Mark E DeVries, et al.
The Journal of Clinical Endocrinology and Metabolism|May 25, 2024
Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal TestKieren J Mather, Andrea Mari, Tim Heise, et al.
Experimental Brain Research|January 5, 2019
Use of imperceptible wrist vibration to modulate sensorimotor cortical activityNa Jin Seo, Kishor Lakshminarayanan, Abigail W Lauer, et al.
Investigative Ophthalmology & Visual Science|September 18, 2025
Absence of Glaucoma in Tg-MYOCY437H Mice of Diverse Genetic BackgroundsNicholas G Tolman, Marina Simón, Felicia A Juarez, et al.
Heart Rhythm O2|February 24, 2026
Factors associated with complexity during transvenous lead extraction and confirmation of a very-low-risk subsetEmma Francis, John A Anderson, Emmanuel Danso, et al.
Cancer Immunology Research|September 6, 2014
A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-TDouglas G McNeel, Thomas A Gardner, Celestia S Higano, et al.
The Journal of Biological Chemistry|April 14, 2005
Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosisYankun Li, Robert F Schwabe, Tracie DeVries-Seimon, et al.
ASAIO Transactions|July 1, 1988
Nine year experience with the clinical use of total artificial hearts as cardiac support devicesL D Joyce, K E Johnson, C Cabrol, et al.
Pageof 232